18.53
Schlusskurs vom Vortag:
$18.63
Offen:
$18.64
24-Stunden-Volumen:
4.54M
Relative Volume:
1.76
Marktkapitalisierung:
$4.44B
Einnahmen:
$684.29M
Nettoeinkommen (Verlust:
$97.17M
KGV:
45.20
EPS:
0.41
Netto-Cashflow:
$309.31M
1W Leistung:
+0.65%
1M Leistung:
+0.38%
6M Leistung:
+11.09%
1J Leistung:
+13.47%
Sabra Healthcare Reit Inc Stock (SBRA) Company Profile
Firmenname
Sabra Healthcare Reit Inc
Sektor
Telefon
888-393-8248
Adresse
1781 FLIGHT WAY, TUSTIN, CA
Vergleichen Sie SBRA mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
SBRA
Sabra Healthcare Reit Inc
|
18.53 | 4.47B | 684.29M | 97.17M | 309.31M | 0.41 |
![]()
WELL
Welltower Inc
|
163.04 | 110.22B | 9.14B | 1.13B | 2.56B | 1.77 |
![]()
VTR
Ventas Inc
|
68.01 | 31.14B | 5.08B | 142.33M | 797.33M | 0.33 |
![]()
DOC
Healthpeak Properties Inc
|
17.14 | 11.81B | 2.80B | 279.29M | 1.20B | 0.40 |
![]()
CTRE
Caretrust Reit Inc
|
33.08 | 6.59B | 219.54M | 99.24M | 205.68M | 0.72 |
![]()
AHR
American Healthcare Reit Inc
|
40.65 | 6.83B | 2.07B | -37.81M | 84.15M | -0.27 |
Sabra Healthcare Reit Inc Stock (SBRA) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-01-17 | Herabstufung | Truist | Buy → Hold |
2025-01-07 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
2024-12-05 | Herabstufung | Mizuho | Outperform → Neutral |
2024-10-01 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
2024-09-13 | Hochstufung | Citigroup | Neutral → Buy |
2024-01-30 | Eingeleitet | Deutsche Bank | Buy |
2023-10-17 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
2023-10-16 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
2023-10-10 | Hochstufung | BofA Securities | Neutral → Buy |
2023-10-03 | Eingeleitet | Wedbush | Outperform |
2023-09-20 | Hochstufung | Jefferies | Hold → Buy |
2023-08-11 | Hochstufung | BofA Securities | Underperform → Neutral |
2023-07-27 | Eingeleitet | Berenberg | Hold |
2023-04-20 | Eingeleitet | Wells Fargo | Underweight |
2022-12-13 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
2022-11-14 | Herabstufung | BofA Securities | Neutral → Underperform |
2022-10-10 | Herabstufung | Robert W. Baird | Outperform → Neutral |
2022-06-30 | Herabstufung | Jefferies | Buy → Hold |
2022-06-03 | Eingeleitet | CapitalOne | Equal Weight |
2022-05-25 | Hochstufung | Mizuho | Neutral → Buy |
2022-04-18 | Herabstufung | Barclays | Overweight → Equal Weight |
2022-03-11 | Hochstufung | BofA Securities | Underperform → Neutral |
2022-02-18 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
2022-02-01 | Eingeleitet | Credit Suisse | Neutral |
2021-10-08 | Eingeleitet | Robert W. Baird | Outperform |
2021-09-30 | Hochstufung | Truist | Hold → Buy |
2021-07-14 | Fortgesetzt | Mizuho | Neutral |
2021-05-21 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
2021-05-10 | Hochstufung | Stifel | Hold → Buy |
2021-01-13 | Hochstufung | Jefferies | Hold → Buy |
2021-01-13 | Herabstufung | Mizuho | Buy → Neutral |
2021-01-08 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
2020-12-03 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
2020-09-02 | Fortgesetzt | Stifel | Hold |
2020-06-23 | Hochstufung | Scotiabank | Sector Underperform → Sector Perform |
2020-06-08 | Fortgesetzt | JMP Securities | Mkt Perform |
2020-05-18 | Hochstufung | Berenberg | Hold → Buy |
2020-03-23 | Herabstufung | BofA/Merrill | Neutral → Underperform |
2020-02-26 | Hochstufung | Mizuho | Neutral → Buy |
2020-02-05 | Eingeleitet | Berenberg | Hold |
2019-12-20 | Eingeleitet | Mizuho | Neutral |
2019-12-18 | Hochstufung | Citigroup | Sell → Neutral |
2019-10-14 | Fortgesetzt | BofA/Merrill | Neutral |
2019-09-23 | Herabstufung | Citigroup | Neutral → Sell |
2019-09-03 | Eingeleitet | Barclays | Overweight |
2018-12-18 | Herabstufung | SunTrust | Buy → Hold |
2018-11-16 | Herabstufung | BofA/Merrill | Neutral → Underperform |
2018-05-21 | Hochstufung | Raymond James | Mkt Perform → Outperform |
2018-03-26 | Hochstufung | BofA/Merrill | Underperform → Neutral |
2018-02-22 | Bestätigt | Stifel | Hold |
2017-12-21 | Herabstufung | Jefferies | Buy → Hold |
2017-09-25 | Eingeleitet | CapitalOne | Equal Weight |
Alle ansehen
Sabra Healthcare Reit Inc Aktie (SBRA) Neueste Nachrichten
Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Shares Sold by Cetera Investment Advisers - MarketBeat
Sabra Healthcare REIT (NASDAQ:SBRA) Given New $22.00 Price Target at JMP Securities - MarketBeat
New Age Alpha Advisors LLC Has $3.20 Million Stock Position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) - MarketBeat
Sabra Healthcare REIT, Inc. Announces Quarterly Dividend of $0.30 (NASDAQ:SBRA) - MarketBeat
Sabra Healthcare REIT (NASDAQ:SBRA) Updates FY 2025 Earnings Guidance - MarketBeat
Jupiter Asset Management Ltd. Increases Stock Position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) - MarketBeat
Cetera Investment Advisers Has $1.83 Million Stock Position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) - Defense World
Sabra Healthcare REIT (NASDAQ:SBRA) Posts Earnings Results, Beats Estimates By $0.02 EPS - MarketBeat
XTX Topco Ltd Acquires 26,253 Shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) - MarketBeat
LSV Asset Management Sells 22,700 Shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) - MarketBeat
Mutual of America Capital Management LLC Has $8.13 Million Position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) - Defense World
Sabra Healthcare Reit: Positive Earnings Call Highlights - TipRanks
Sabra Healthcare REIT stock price target raised to $22 at Citizens JMP - Investing.com India
Sabra Health Care REIT on track to invest up to $500 million in 2025 as it moves to increase senior housing in portfolio - McKnight's Senior Living
Sabra Healthcare REIT Maintains Stable Risk Outlook Amid 2024 Assessment - TipRanks
Sabra Healthcare REIT Reports Strong Q2 2025 Results - TipRanks
Sabra Health Care REIT: Capitalizing on the Silver Tsunami in Senior Housing and Skilled Nursing - AInvest
Sabra Health Care REIT's Q2 2025: Navigating Contradictions in Investment Strategy and Occupancy Trends - AInvest
Sabra Health Care REIT, Inc. 2025 Q2ResultsEarnings Call Presentation (NASDAQ:SBRA) - Seeking Alpha
Sabra Healthcare REIT Announces New Equity Distribution - TipRanks
Sabra Health Care REIT files for mixed shelf size not disclosedSEC filing - MarketScreener
Earnings call transcript: Sabra Healthcare REIT beats Q2 2025 forecasts - Investing.com
Assetmark Inc. Grows Position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) - Defense World
Pacer Advisors Inc. Sells 17,638 Shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) - MarketBeat
What makes Sabra Health Care REIT Inc. stock price move sharplyHigh Yield Watchlist with Filtered Picks - Newser
Sabra Health Care REIT Grows On Senior Housing Strength - Finimize
Sabra: Q2 Earnings Snapshot - Greenwich Time
Real Estate Stocks Under Scrutiny: Analysts' Divergent Views on Simon Property, CapitaLand Ascendas REIT, and Sabra Healthcare REIT - AInvest
Sabra (SBRA) Q2 Revenue Jumps 7.4% - The Motley Fool
Sabra Healthcare REIT Q2 2025 presentation: Strategic positioning drives 4% NAFFO growth - Investing.com India
Sabra Healthcare REIT Q2 2025 presentation: Strategic positioning drives 4% NAFFO growth By Investing.com - Investing.com South Africa
Sabra Healthcare REIT Updates 2025 Earnings Guidance - TipRanks
Sabra Reports Second Quarter 2025 Results; Updates 2025 Guidance - Business Wire
What institutional investors are buying Sabra Health Care REIT Inc. stockTop Growth Trend Scanner With High Returns - Jammu Links News
Jefferies Financial Group Inc. Buys 1,445,909 Shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) - MarketBeat
Sabra Healthcare REIT (SBRA) to Release Quarterly Earnings on Monday - Defense World
Sabra Health Care REIT Earnings Preview - 富途牛牛
Sabra Health Care REIT continues to execute on sustainability efforts - McKnight's Senior Living
Sabra Healthcare REIT Redeems Senior Notes and Optimizes Capital - TipRanks
Finanzdaten der Sabra Healthcare Reit Inc-Aktie (SBRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):